全文获取类型
| 收费全文 | 5549篇 |
| 免费 | 454篇 |
| 国内免费 | 162篇 |
专业分类
| 耳鼻咽喉 | 78篇 |
| 儿科学 | 171篇 |
| 妇产科学 | 119篇 |
| 基础医学 | 803篇 |
| 口腔科学 | 80篇 |
| 临床医学 | 627篇 |
| 内科学 | 919篇 |
| 皮肤病学 | 88篇 |
| 神经病学 | 661篇 |
| 特种医学 | 232篇 |
| 外科学 | 916篇 |
| 综合类 | 65篇 |
| 一般理论 | 5篇 |
| 预防医学 | 610篇 |
| 眼科学 | 123篇 |
| 药学 | 310篇 |
| 中国医学 | 5篇 |
| 肿瘤学 | 353篇 |
出版年
| 2023年 | 25篇 |
| 2022年 | 41篇 |
| 2021年 | 132篇 |
| 2020年 | 76篇 |
| 2019年 | 135篇 |
| 2018年 | 135篇 |
| 2017年 | 69篇 |
| 2016年 | 108篇 |
| 2015年 | 125篇 |
| 2014年 | 171篇 |
| 2013年 | 255篇 |
| 2012年 | 326篇 |
| 2011年 | 367篇 |
| 2010年 | 183篇 |
| 2009年 | 166篇 |
| 2008年 | 272篇 |
| 2007年 | 315篇 |
| 2006年 | 295篇 |
| 2005年 | 295篇 |
| 2004年 | 302篇 |
| 2003年 | 254篇 |
| 2002年 | 265篇 |
| 2001年 | 145篇 |
| 2000年 | 122篇 |
| 1999年 | 122篇 |
| 1998年 | 67篇 |
| 1997年 | 55篇 |
| 1996年 | 50篇 |
| 1995年 | 43篇 |
| 1994年 | 39篇 |
| 1993年 | 32篇 |
| 1992年 | 64篇 |
| 1991年 | 64篇 |
| 1990年 | 60篇 |
| 1989年 | 50篇 |
| 1988年 | 75篇 |
| 1987年 | 51篇 |
| 1986年 | 56篇 |
| 1985年 | 54篇 |
| 1984年 | 41篇 |
| 1983年 | 34篇 |
| 1982年 | 36篇 |
| 1981年 | 27篇 |
| 1980年 | 28篇 |
| 1979年 | 51篇 |
| 1978年 | 35篇 |
| 1977年 | 25篇 |
| 1975年 | 36篇 |
| 1973年 | 29篇 |
| 1972年 | 26篇 |
排序方式： 共有6165条查询结果，搜索用时 15 毫秒
1.
Osric A. Forrest Daniel M. Chopyk Yael Gernez Milton R. Brown Carol K. Conrad Richard B. Moss Vin Tangpricha Limin Peng Rabindra Tirouvanziam 《Journal of cystic fibrosis》2019,18(1):64-70
Background
Resistin is an immunometabolic mediator that is elevated in several inflammatory disorders. A ligand for Toll-like receptor 4, resistin modulates the recruitment and activation of myeloid cells, notably neutrophils. Neutrophils are major drivers of cystic fibrosis (CF) lung disease, in part due to the release of human neutrophil elastase- and myeloperoxidase-rich primary granules, leading to tissue damage. Here we assessed the relationship of resistin to CF lung disease.Methods
Resistin levels were measured in plasma and sputum from three retrospective CF cohorts spanning a wide range of disease. We also assessed the ability of neutrophils to secrete resistin upon activation in vitro. Finally, we constructed a multivariate model assessing the relationship between resistin levels and lung function.Results
Plasma resistin levels were only marginally higher in CF than in healthy control subjects. By contrast, sputum resistin levels were very high in CF, reaching 50–100 fold higher levels than in plasma. Among CF patients, higher plasma resistin levels were associated with allergic bronchopulmonary aspergillosis, and higher sputum resistin levels were associated with CF-related diabetes. Mechanistically, in vitro release of neutrophil primary granules was concomitant with resistin secretion. Overall, sputum resistin levels were negatively correlated with CF lung function, independently of other variables (age, sex, and genotype).Conclusions
Our data establish relationships between resistin levels in the plasma and sputum of CF patients that correlate with disease status, and identify resistin as a novel mechanistic link between neutrophilic inflammation and lung disease in CF. 相似文献2.
3.
C. Jacquet F. Goehringer E. Baux J.A. Conrad M.O. Ganne Devonec J.L. Schmutz G. Mathey H. Tronel T. Moulinet I. Chary-Valckenaere T. May C. Rabaud 《Médecine et maladies infectieuses》2019,49(2):112-120
Objective
The teaching hospital of Nancy, France, implemented a specific multidisciplinary care pathway (French acronym AMDPL) to improve the management of patients presenting with Lyme borreliosis (LB) suspicion. We aimed to assess the first year of activity of this care pathway.Patients and methods
We included all patients managed in the AMDPL pathway from November 1, 2016 to October 31, 2017. The first step was a dedicated Lyme disease consultation with an infectious disease specialist. Following this consultation, the LB diagnosis was either confirmed and adequate treatment was prescribed, or a differential diagnosis was established and patients received adequate management, or further investigations were required and patients were offered multidisciplinary management as part of a day hospitalization.Results
A total of 468 patients were included. LB diagnosis was confirmed in 15% of patients (69/468), 49% of patients received a differential diagnosis, and 26% (122/468) of patients had the LB diagnosis ruled out without receiving any other diagnosis.Conclusions
This is to our knowledge the first multidisciplinary center implemented in France for the management of patients presenting with LB suspicion related to polymorphous signs and symptoms. Several diagnoses could be confirmed or corrected, although some symptoms and complaints could not be explained. This cohort could improve our knowledge of LB and its differential diagnoses. 相似文献4.
5.
6.
D-xylose disposition was examined in 24 healthy men between 32 and 85 years of age. Xylose was administered as a 5 gm iv infusion and as a 25 gm po solution. Serum xylose concentrations and urinary excretion of intact xylose were determined. There were statistically significant inverse relationships with age for each of the following parameters after intravenous infusion: elimination rate constant (r2 = 0.71); systemic clearance (r2 = 0.66); renal clearance (r2 = 0.66); and nonrenal clearance (r2 = 0.35). Similar inverse relationships were found after oral dosing for the elimination rate constant (r2 = 0.69) and renal clearance (r2 = 0.54). There was no significant age relationship for the apparent volume of distribution or the steady-state volume of distribution. The percentage of the oral and intravenous dose recovered in urine up to 5 hours after dosing was significantly and inversely correlated with age. The implications of the latter finding are discussed with regard to the interpretation of the xylose tolerance test used to assess gastrointestinal absorptive capacity. 相似文献
7.
8.
9.
10.